Page last updated: 2024-10-24

cefuroxime and Leprosy

cefuroxime has been researched along with Leprosy in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shepard, CC1
Van Landingham, RM1
Walker, LL1
Good, RC1

Other Studies

1 other study available for cefuroxime and Leprosy

ArticleYear
Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1987, Volume: 55, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Cefoxitin; Cefuroxime; Cephalosporins; Female; Leprosy; Mezlocillin;

1987